MedPath

Small Intestinal Bacterial Overgrowth Obese

Not Applicable
Completed
Conditions
Chromatography, Gas
Bacterial Overgrowth Syndrome
Gastric Bypass
Blind Loop Syndrome
Interventions
Procedure: gas chromatography
Procedure: Stool analysis for detection of malabsorption
Registration Number
NCT02819037
Lead Sponsor
Lille Catholic University
Brief Summary

The objective of this research is to determine the incidence of microbial overgrowth of the small intestine before and after a gastric bypass. For this purpose, the study is based on the analysis of the expired hydrogen H2 with gas chromatography before surgery and at 1, 3, 6, 12, 18 and 24 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Severe obesity (BMI>35kg/m² with at least one comorbidity or BMI>40kg/m² without comorbidity) and after medical care for at least 6 months
  • Patient who will follow bariatric surgery by bypass gastric
  • Social insurance affiliation
  • Signature of the informed consent
Exclusion Criteria
  • Contraindication criteria for bariatric surgery (cognitive or mental severe disorders, severe and non-stabilized eating disorders, etc.)
  • Chronic inflammatory bowel disease (Crohn's disease, hemorrhagic rectocolitis)
  • Previous intestinal surgery
  • Antibiotic periodicity treatment of less than 3 months
  • Other diseases responsible for bacterial overgrowth
  • Pregnancy or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Gas chromatography and stool analysisgas chromatographygas chromatography and stool analysis for detection of malabsorption
Gas chromatography and stool analysisStool analysis for detection of malabsorptiongas chromatography and stool analysis for detection of malabsorption
Primary Outcome Measures
NameTimeMethod
Changes in expired hydrogen H2 concentrationchange at baseline et up to 24 months

Measured by gas chromatography

Secondary Outcome Measures
NameTimeMethod
Changes in intestinal transitchange at baseline et up to 24 months

Characterisation of intestinal transit by measuring stool frequency

Changes in malabsorptionchange at baseline et up to 24 months

Detection of lipids, vitamins (A, B1, B9, B12, D, E), zinc, magnesium, phosphorus, serum iron and protein balance (albumin, prealbumin, CRP) in order to diagnosis the presence of malabsorption

Changes in digestive symptomschange at baseline et up to 24 months

Trial Locations

Locations (2)

Centre Hospitalier d'Arras

🇫🇷

Arras, France

Centre Hospitalier de Douai

🇫🇷

Douai, France

© Copyright 2025. All Rights Reserved by MedPath